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Abstract
Here we describe emergent properties of the brain and the key challenges associated with
modelling them in vitro. Modelling emergent properties of the brain will provide insights into
brain function, development and disease.

Manuscript
Many properties of complex systems are emergent: they are the result of the collective
activities of a system’s components, and yet are strikingly different from any of the properties
that those individual components bear (Corradini and O’Connor 2010)(McClelland 2010). In
neuroscience, one obvious example of such a property is consciousness, which somehow
arises from the collective activities of huge numbers of neurons and their supportive cells. As
far as anyone can tell, none of the properties of individual neurons resembles consciousness,
and while consciousness can be affected in predictable ways by drugs and disorders, no
mechanistic explanation for it has yet been found. The problem of understanding
consciousness lies in understanding how it emerges from all that underlying non-conscious
activity.
Consciousness isn’t the only emergent property relevant to neuroscience. As we increase in
complexity moving from individual ion channels and membrane proteins to individual
neurons through to circuits and tissues (Figure 1), we deal repeatedly with systems that, when
brought together, exhibit properties that are new, interesting and often unexpected.
Emergence is beginning to be discussed in relation to computational models of neural
systems (Turkheimer and others 2019), but not in tissue models. One recent example of
emergent phenomena occurring in tissue models used human neural progenitor cells (hNPC)
with amyloid precursor protein (APP) or APP and presenilin 1 (PSEN1) familial Alzheimer’s
disease (FAD) mutations (Choi and others 2014). When the cells were grown in 2dimensional tissue culture, there was an increased production of amyloid-β, but only in 3dimensional cultures were amyloid-β plaques and tau tangles formed (Figure 2). This change
in protein organisation emerges from a change in tissue structure and may subsequently lead
to large changes in neural networks.

Emergent phenomena can occur in ways which are very difficult to anticipate. For instance,
Alzheimer’s disease is investigated in various animal models (Sasaguri and others 2017).
Three APP overexpressing mouse lines (APP/PSEN1, Tg2576, hAPP-J20) were assessed
with high resolution serial 2-photon tomography of labelled plaques (Figure 3) (Whitesell and
others 2019). The APP/PSEN1 and Tg2576 mice, displayed plaques initially in the isocortex,
followed by olfactory, hippocampal, and cortical subplate regions. In hAPP-J20 mice, the
plaque density was highest in the hippocampal areas, followed by the isocortex, with little to
no plaques formed in the olfactory or cortical subplate areas. Overall, distinct regions were
identified with high or low plaque accumulation (the lateral visual area within the isocortex
of APP/PSEN1 mice had relatively higher plaque density compared to other cortical areas,
while hAPP-J20 mice displayed the densest plaques in the ventral retrosplenial cortex). This
work demonstrates that emergent phenomena may not be uniform throughout neural tissue,
consistent with human studies (Grothe and others 2017). The spatial and temporal pattern of
emergent phenomena can also vary between models, and hence the use of an appropriate
model is crucial in testing the clinical relevance of emergent phenomena. For example,
despite displaying emergent plaque formation, these knock‐in mice do not exhibit tau
pathology or neurodegeneration (Sasaguri and others 2017). While this may be due to the
limited lifetime of the animal models, it indicates that although APP/PSEN1 mutations
induce behavioural deficits, the emergence of plaques is not a cause of neurodegeneration in
these mice.
Neural function is typically investigated through electrophysiological methods. In tissue
culture, the electrophysiological behaviour may be relatively homogeneous. However the
brain can display distinct patterns of electrophysiological activity. For instance,
electrophysiological behaviour of grid cells in the entorhinal cortex exhibit a hexagonal
topographical structure (Hafting and others 2005). It is thought that grid cells form the basis
of spatiotemporal representation of places, routes, and associated experiences during
behaviour and in memory (Moser and others 2008). This type of complex neural structure is
being modelled computationally (Solstad and others 2006) (Tait and others 2018), but is
largely unreplicated in tissue culture models because biofabrication methods have thus far not
been able to create realistic neural tissue complexity.
Recognising the role of emergence in neural phenomena is crucial for developing a better
understanding of the function of healthy brains and the ways in which brain function can be
affected by disease. Such diseases are often associated with changes that could disrupt
healthy emergent properties and behaviours, introduce new, harmful ones or display
emergent symptoms. These changes can include the loss of cell types, the degradation of
neural networks and the build-up of aggregated proteins, such as amyloid plaques or Lewy
bodies. Investigating these possibilities requires an understanding of the variety of types of
emergent properties and behaviours that can be found in the brain.
Healthy neural function and disease are often investigated through different tissue models.
These include 2-dimensional and more recently 3-dimensional cell cultures, organoids, tissue
slices, live animal models and finally human clinical trials. There are limitations in each of
these models (Wellbourne-Wood and Chatton 2018). Cell cultures are often composed of a
single immortalised or primary cell type, although co-cultures of multiple cell types are
possible. Immortalised cell lines and different animal models allow investigation of
biological mechanisms, but differences in genetic sequence lead to vast differences in
structure, composition and signalling, and thus may have a poor relevance to human disease

(Götz and others 2018). Human tissue from normal and diseased people can be used to form
cell cultures and organoids, providing more relevant data on biological mechanisms (Choi
and others 2014)(Raja and others 2016)(Amin and Paşca 2018). However, the developmental
stage of these tissues is not the same as in an adult living being, so the level of neural
networks and development of aged disease phenotypes in the model are not equivalent to
those in the target system. Finally, tissue slices are only feasible after a patient has deceased,
while the amount of invasive testing allowed during clinical trials is limited for ethical
reasons. As a result, a lot of extrapolation is required between different tissue models to
determine the causes and progression of diseases.
Successfully extrapolating across different models is possible when those models accurately
capture the relevant features of individual components. In the simplest cases, the properties of
individual cells ‘add up’ to the whole brain structure and function. In those cases,
extrapolations from a simple tissue model are relatively straightforward: the properties we
study in the tissue model simply have to be magnified to give an appropriate prediction
concerning the brain. Complete understanding requires tissue models that are complex
enough to display similar emergent behaviours themselves: we need to generate the emergent
properties in the tissue model in order to understand it in the target system. Only then can we
be confident that our tissue models have captured the relevant underlying features.
Tissue models involve a wide variety of simplifications compared to real brains, including
simplifications in cellular structure, network connectivity, morphology, neural function, cell
type, sensory input and output, and chemical input (Wellbourne-Wood and Chatton 2018).
Neurons in a tissue model may display certain axon and dendrite structure with various ion
channels and synapses, but in the whole brain a wider variety of cell types and structures are
found. In a tissue model, a limited number of connections are made across the neurons
present, while in the whole brain, larger neural networks can form, and they can cross
different brain regions. Tissue models are often a 2-dimensional network, in the brain 3dimensional structures form, and in primates and humans, cortical folds provide a very high
surface area. Tissue models show limited coordinated function, whereas the brain shows
distinct regions that are able to perform functions such as retaining memory. Tissue models
are often composed of limited cell types, in the brain, multiple cell types are present which
will alter neural behaviour. Tissue models have limited sensory input and output, while in the
brain, connections with other organs such as the eye and to muscles leads to formation of new
types of connections and feedback mechanisms. Tissue models have limited chemical input,
while in the brain, hormones and other drugs can affect neural behaviour. In all of these
cases, simple tissue models omit features that could be most relevant for producing the
emergent phenomena they are supposed to help us understand.
Tissue models aren’t the only method for investigating the brain. Computer models are also
used to understand cellular and network behaviour. These models balance complexity with
cost and speed of computation, implementing different mathematical representations of
cellular or network function. While these models can create some emergent phenomena, they
are limited by the choice of neural features being modelled (Markram and others 2015). For
instance, a model of electrophysiological response in neural networks often does not provide
mechanistic biochemical information. Emergent phenomena generated by interactions
between these features would not arise in such a model. Extrapolation from the model to the

target system would be hampered by the fact that the model has not captured the relevant
underlying features.
The challenge of studying emergence is in anticipating which underlying features are
relevant, and which simplifications in a model are allowable (Gan and others 2018).
Emergent phenomena may arise at many different scales, involving interactions of molecules,
cells, brain regions, organs or organisms. They may be the result of the number of
components interacting together (e.g. large numbers of molecules, cells, connections), the
specific type of components present (e.g. certain types of cells), or their arrangement (e.g.
within a neural network) (Figure 4). For instance, in determining the impact of amyloid-β
plaques and tau tangles in Alzheimer’s disease, and to develop effective treatments, the effect
of tissue structure must be investigated.
In order to understand brain diseases and develop effective treatments, we need to develop a
range of models, covering different cellular, network and cognitive functions (Bassett and
others 2018). This is the best way to ensure that the relevant features underlying emergent
phenomena are captured in our models. Animal models may display similar neural function,
however variations in genes may have a large impact on the mechanisms behind this
behaviour (Götz and others 2018)(Dawson and others 2018). Cell cultures may show cellular
structure and the development of synapses, but without other cell types, such as
oligodendrocytes and microglia, myelination won’t occur and the impact of the immune
response is omitted (Madhavan and others 2018). A human derived organoid can display
some neural structure involving several cell types, but the developmental stage limits cell
maturation and lack of vasculature limits organoid size, preventing development of large
neural networks and complex structure (Choi and others 2014)(Amin and Paşca 2018). Only
by integrating a range of models can we hope to capture the relevant features of a disease
process (Bassett and others 2018).
Mapping the degradation in cognitive function with disease progression can provide clues to
the relevant components underlying emergent phenomena, but it doesn’t eliminate the
possibility that a more complex mechanism is occurring. By having a range of models, the
relevant emergent phenomena promotes understanding of normal brain function and for
developing treatments for disease (Bassett and others 2018). One approach is to develop
new, more complex models that display different emergent phenomena than currently
available in cell culture. This will involve controlling the cell number, types and their
arrangement to determine these effects on emergent properties in neural function and disease.
This may be achieved by further development of tissue engineering methods such as 3D
bioprinting (Figure 5) (Zhuang and others 2018). It will also define the limitations of simpler
models currently in use. The outcome will be to incorporate the concepts of emergence into
tissue modelling in order to understand neural function and neurodegenerative disease.
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Figure 1: The complexity of tissue increases across different models. Low complexity
models allow investigation of cellular behaviour, but may not capture sufficient information
or be sufficiently accurate to explain more complex tissue relevant to the human brain and
neurodegenerative disease.
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(b)

Figure 2: Formation of amyloid-β plaques in 3D culture using differentiated hNPCs with
FAD mutations. (a) 3D culture protocol, (b) amyloid-β deposits in 6-week differentiated
control (ReN-G), APP (ReN-GA) or APP/PSEN1 (ReN-mGAP) cells (green, GFP; blue,
3D6; scale = 25 µm; arrowheads, extracellular amyloid-β deposits; right-most panels, 3D6
staining was pseudo-coloured to red). Adapted with permission from: (Choi and others 2014)

Figure 3: Plaque distribution across cortical layers differs between mouse models. Images
showing plaques in the parietal cortex of 19-month-old (a) APP/PSEN1, (c) Tg2576, and (e)
hAPP-J20 mice. Approximate layer boundaries are indicated in text to the right of each image
(wm = white matter). Scale = 500 μm. The relative plaque density in each cortical layer
across the entire isocortex is plotted separately for (b) APP/PS1, (d) Tg2576, and (f) hAPPJ20 mouse lines. Box plots show median and IQR with whiskers extending up to 1.5 times
the IQR. Outliers are plotted as individual points. Adapted with permission from: (Whitesell
and others 2019)
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Figure 4: Representative diagram showing the relationship between emergent phenomena
and simplified models across three dimensions. The shaded areas represent groups of systems
with similar patterns of behaviour. For the inner areas, the behaviours are sufficiently similar
to allow for reliable extrapolation. Emergent phenomena involve drastic changes in behaviour
that can no longer be reliably captured by simplified models.

Figure 5: An overview of current in vitro neural tissue models. Cell biology-based models
include spheroids and organoids, which are heavily dependent on spontaneous cell
organization, resulting in a highly variable structure and composition. Engineering-based
models include scaffold-based and microfluidics, which impose better control over matrix
organization and tissue structure. Bioprinting combines the strengths of cell biology and
engineered models by integrating cells, scaffolds and microfluidics into one neural tissue
model with better quality and consistency. Adapted with permission from: (Zhuang and
others 2018)

